Related Experiment Video

Updated: Jun 3, 2026

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells

Kazuaki Chikamatsu1, Hiroki Ishii, Goro Takahashi

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Yamanashi, Faculty of Medicine, Chuo, Yamanashi, 409-3898, Japan. chikamatsu@yamanashi.ac.jp

Head & Neck
|April 8, 2011
PubMed
Abstract

Insights

Cancer stem cells (CSCs) in head and neck squamous cell carcinoma (HNSCC) exhibit resistance to apoptosis, mediated by CD44 expression. Targeting these CD44+ CSCs requires novel therapeutic strategies for HNSCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • CD44 is a marker for cancer stem cells (CSCs) in head and neck squamous cell carcinoma (HNSCC).
  • Apoptosis resistance mechanisms in HNSCC CSCs are not fully understood, hindering effective cancer treatment.

Purpose of the Study:

  • To investigate the role of CD44 in apoptosis resistance of HNSCC CSCs.
  • To elucidate the molecular mechanisms underlying treatment resistance in HNSCC CSCs.

Main Methods:

  • Compared apoptosis sensitivity of CD44+ and CD44- cells to various stimuli.
  • Analyzed cell cycle distribution using flow cytometry.
  • Quantified expression of anti-apoptosis genes (Bcl-2, IAPs) via RT-PCR.

Main Results:

  • CD44+ HNSCC cells demonstrated significant resistance to apoptosis-inducing agents.
  • CD44+ cells exhibited an increased proportion in the G2/M phase of the cell cycle.
  • Upregulation of Bcl-2 and inhibitor of apoptosis (IAP) family genes was observed in CD44+ cells.

Conclusions:

  • Treatment resistance in HNSCC CSCs is multifactorial, involving CD44 expression.
  • Novel therapeutic strategies targeting CD44+ CSCs are essential for improving HNSCC patient outcomes.

More Related Videos

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...